-
Panic, anger, tears: Evan Gershkovich's uneasy journey after Russian jail
-
Bohm's blast keeps Phillies alive in MLB playoffs
-
UK PM says 'strong indications' Iran involved in airbase incident
-
US judge accepts Paramount's Warner Bros. buyout settlement
-
Google restricts access to new AI model over safety concerns
-
Global stocks mixed as markets weigh higher oil prices, bond yields
-
Watchdog clears former US Fed chief Powell in renovation probe
-
Marsh hails improvements after Australia win final one-day international
-
Israel PM hails Indian pilot of rerouted flight for averting disaster
-
Hegseth says US cut number of generals, admirals by 20%
-
Fury, Joshua kick off 'battle of Britain' in good spirits
-
Kanye West's Russian concerts have been cancelled, organisers say
-
Ronaldo leaves Portugal training camp after coach says he is dropped
-
First Hollywood, now Fat Bear Week: nepobaby wins Alaska contest
-
Florence Pugh stars in 'East of Eden' adaption on Netflix
-
Barcelona lay down marker in Women's Champions League, Arsenal slip up
-
Watchdog finds no criminal misconduct over US Fed renovations despite Trump probe
-
US pushes against overproduction with eye on China at G20 meeting
-
In Manchester, City fans 'devastated' while rival fans call for relegation
-
Swiss FA withdraws support for FIFA chief Infantino
-
UK-France Channel migrant exchange deal scrapped: London
-
Man City's meteoric rise clouded by financial scandal
-
Portugal boss denies 'incident' with Ronaldo
-
Polish activists open first abortion pill locker in Warsaw
-
Israel PM says one of the pilots of rerouted flight tried to crash plane
-
NHL Avalanche ink Bednar to four-year coaching deal
-
Manchester City: Main points of damning judgement and possible sanctions
-
Polish activists opens first abortion pill locker in Warsaw
-
Italy looking for 'identity' under Mancini says Scalvini
-
Turkey says news site closed for 'LGBTQ propaganda'
-
The voices of Spain's housing camp protesters
-
Oil companies close in on Venezuela despite hurdles
-
Romanian parliament rejects pro-EU PM candidate
-
Turkey freezes ex-minister's assets as fund scandal grows
-
Court halts Tennessee's first execution of woman in 200 years
-
Guardiola backs Man City after bombshell guilty verdicts
-
Israelis march between once-closed West Bank settlements
-
G20 trade ministers open talks under strain of Trump tariffs
-
'Welcome back,' says Macron, as UK PM opens door to EU return
-
France in talks with UK to end 2025 migrant accord: ministry
-
Israel PM says pilot of rerouted flight tried to crash plane
-
Europe's surging inflation spreads gloom in stock markets
-
Demuro hopes to deliver Japan a 'magical' Arc victory
-
Truth commission demands compensation for Sweden's Sami people
-
'Devastated' AI scandal author Orelien returns to Quebec
-
Japan win marathon penalty shootout to set up South Korea gold-medal clash
-
US reports firm Q2 economic growth, inflation steady
-
Djokovic grinds out opening-round win at China Open
-
Energy costs spark inflation surge across Europe
-
Northern Ireland police probe blockade of disputed parade
France warns against weight loss supplements using Garcinia plant
France warned Wednesday against dietary supplements promising weight loss that use the tropical plant Garcinia cambogia after a range of rare but serious side effects including one death were reported.
Garcinia cambogia -- which is also called Garcinia gummi-gutta or Malabar tamarind -- grows in India and Southeast Asia and has a fruit that looks like a pumpkin.
A range of supplements are sold around the world using extracts from the plant advertising its ability to suppress appetite and drive weight loss -- claims not backed by comprehensive scientific evidence.
After investigating the death of a person who took a Garcinia-based supplement -- and looking at other side effects reported in the United States and elsewhere -- French food safety agency ANSES said it "strongly advises" people against consuming the plant.
The plant has been banned from being used medicine since 2012 in France, but continues to be advertised in more 340 dietary supplements, which are mostly available online, the agency said in a statement.
There were 38 cases of serious side effects affecting the liver, pancreas, heart, muscles and mental health reported in France between 2009 and March last year, ANSES said.
These side effects can affect people with a history of psychiatric disorders, pancreatitis or hepatitis -- or who suffer from diabetes, obesity or high blood pressure, the agency added.
People taking antidepressants, antiretrovirals or drugs that affect the liver can also experience side effects.
A 71-year-old woman in France taking blood pressure drugs died of acute hepatitis in 2019 after taking Garcinia-based supplement Slim Metabol. ANSES says her death was "very likely" linked to the supplement, which remains on sale.
However people without a history of health problems can also be affected.
"A 32-year-old woman with no medical history developed myocarditis that led to her requiring a heart transplant," Aymeric Dopter, head of the ANSES nutrition risk assessment unit, told AFP.
"Some people will tell you: 'I took it and I am fine'," Dopter said.
"But we can see from these few cases that people who were simply trying to lose weight ended up with seriously impaired health -- or even died," he said.
"It is not the worth the risk."
The safety of products using Garcinia cambogia is currently being assessed by the European Food Safety Agency.
The watchdog is also investigating the risk of hydroxycitric acid, an ingredient extracted from the Garcinia plant's fruit, which is also used in supplements promoting weight loss.
France's ANSES called for the list of plants authorised for use in food supplements to be "harmonised" across the European Union.
C.Meier--BTB